A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Thinned-skull Cortical Window Technique for In Vivo Optical Coherence Tomography Imaging

14.8K views

⸱

DOI:

10.3791/50053

⸱

November 19th, 2012

In This Article

Summary

We present a method of creating a thinned-skull cortical window (TSCW) in a mouse model for in vivo OCT imaging of the cerebral cortex.

Abstract

Optical coherence tomography (OCT) is a biomedical imaging technique with high spatial-temporal resolution. With its minimally invasive approach OCT has been used extensively in ophthalmology, dermatology, and gastroenterology1-3. Using a thinned-skull cortical window (TSCW), we employ spectral-domain OCT (SD-OCT) modality as a tool to image the cortex in vivo. Commonly, an opened-skull has been used for neuro-imaging as it provides more versatility, however, a TSCW approach is less invasive and is an effective mean for long term imaging in neuropathology studies. Here, we present a method of creating a TSCW in a mouse model for in vivo OCT imaging of the cerebral cortex.

Introduction

Since its introduction in the early 1990's, OCT has been used extensively for biological imaging of tissue structure and function2. OCT generates cross-sectional images by measuring echo time delay of backscattered light4 by implementing low coherence light source with a fiber-optic Michelson interferometer2,4. SD-OCT, also known as Fourier domain OCT (FD-OCT), was first introduced in 19955 and offers a superior imaging modality compared with traditional time domain OCT (TD-OCT). In SD-OCT, the reference arm is kept stationary resulting in a high speed and ultra high resolution image acquisition6-9.

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Surgical Preparation

  1. Female CD 1 mice between the ages of 6-8 weeks were used in our experiments.
  2. Anesthetize the mouse with an intraperitoneal injection of a ketamine and xylazine combination (80 mg/kg ketamine/10 mg/kg xylazine). Place the mouse on a homeothermic pad to ensure optimal body temperature at ~37 °C. Continuously monitor level of anesthesia by testing animal's reflexes (e.g., pinching foot with blunt forceps) and inject more anesthesia when necessary.
  3. Lubricate both eyes with an artificial tear ointment. Remove hairs on the scalp using a razor and remove residual hair using 70% alcohol prep pads. Apply a th....

Access restricted. Please log in or start a trial to view this content.

Results

After creating a thinned window over the cerebral cortex the vasculature should now be more visually prominent (Figure 1) and will allow for a deeper imaging depth (up to 1 mm). The right cortex is thinned to approximately 55 μm as compared to a normal skull measured at 140 μm (Figure 1) and provides greater optical clarity. Further thinning to 10-15 μm is possible11 however not necessary as the use of glass cover slips and skull plates are not implemented in our experiments (.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Imaging with OCT and a thinned-skull is a novel neuro-imaging technique that has only been recently investigated15, 16. In our experiments, we demonstrated the feasibility of SD-OCT imaging through a TSCW in a mouse model in vivo. From our results, the skull is thinned to approximately 55 μm and the penetration depth is obtained at approximately 1 mm with image resolution of 8 μm and 20 μm in the axial and lateral direction, respectively. In the signal intensity profile, OCT imaging through a.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

No conflicts of interest declared.

Acknowledgements

This work was supported by the UC Discovery Proof of Concept grant and by the NIH (R00 EB007241). The authors would also like to thank Jacqueline Hubbard for her assistance in this experiment.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
KetaminePhoenix Pharmaceuticals57319-542-02
XylazineAkorn, Inc.139-236
Artificial Tears OintmentRugby0536-6550-91
NairChurch Dwight Co., Inc.4010130
Sterile Alcohol Prep PadKendall Healthcare6818
Cotton Tipped ApplicatorsFisherbrand23-400-115
Betadine Solution SwabstickPurdue Products67618-153-01
Saline Solution, .9%Phoenix Pharmaceuticals57319-555-08
Stereotactic FrameStoelting
High Speed Surgical Hand DrillForedom38,000 rpm
Carbide Round BurStoelting0.75 mm
Dura-Green StonesShofuShank: HP
Shape: BA1
CompoMaster Coarse & CompoMaster PolisherShofuShape: Mini-Pt.
SpaceDrapesBraintree Scientific, Inc.

References

  1. Bizheva, K., Unterhuber, A., Hermann, B., Povazay, B., Sattmann, H., Drexler, W. Imaging ex vivo and in vitro brain morphology in animal models with ultrahigh resolution optical coherence tomography. Journal of Biomedical Optics. 9, 719-724 (2004).
  2. Fujimoto, J. G.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

In Vivo OCT ImagingSpectral Domain OCTMouse Model Brain ImagingSkull Thinning TechniqueDental Burr ApplicationCross Sectional ImagingVolumetric Brain ScanningNeurological Disorder Diagnosis